Gut Microbiome: Both a Friend and a Foe
We Need to Stay on the Gut Microbiome’s Good Side or Risk Microbiota Dysbiosis
Cell-Based, Cell-Free Patches for Cardio Repair
Cardiologists May Now Feel Differently about Quick Patch Ups
Crowdfunding for Science: Models of Best Practice
It’s Not Just the Science That Has to Be Memorable
Genome Editing B.C. (Before CRISPR)
Lasting Lessons from the “Old Testament”
For full access to this article login to GEN Select now.
Quantifying Downstream Capacity Crunch
Column Resins Are Implicated by Many Experts As the Source of Biomanufacturing's Woes
- In today’s biomanufacturing environment, downstream capacity has become a partial roadblock to nearly all CMOs (94%) and more than half (61%) of biotherapeutic developers. Extensive data from 434 biopharmaceutical manufacturers in 32 countries is summarized in BioPlan Associates’ just-released 5th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.